8-K//Current report
CNS Pharmaceuticals, Inc. 8-K
Accession 0001683168-25-008624
$CNSPCIK 0001729427operating
Filed
Nov 20, 7:00 PM ET
Accepted
Nov 21, 5:19 PM ET
Size
973.3 KB
Accession
0001683168-25-008624
Documents
- 8-Kcns_8k.htmPrimary
CURRENT REPORT
- EX-3.1cns_ex0301.htm
CERTIFICATE OF AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION
- EX-10.1cns_ex1001.htm
2020 EQUITY PLAN (AS AMENDED AND RESTATED)
- EX-101.SCHcnsp-20251117.xsd
XBRL SCHEMA FILE
- EX-101.LABcnsp-20251117_lab.xml
XBRL LABEL FILE
- EX-101.PREcnsp-20251117_pre.xml
XBRL PRESENTATION FILE
- GRAPHICimage_005.jpg
GRAPHIC
- GRAPHICimage_006.jpg
GRAPHIC
- GRAPHICimage_007.jpg
GRAPHIC
- GRAPHICimage_008.jpg
GRAPHIC
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001683168-25-008624-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLcns_8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
CNS Pharmaceuticals, Inc.
CIK 0001729427
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001729427
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 20, 7:00 PM ET
- Accepted
- Nov 21, 5:19 PM ET
- Size
- 973.3 KB